Cleveland
BioLabs, Inc.
|
||
(Name
of Issuer)
|
||
Common
Stock
|
||
(Title
of Class of Securities)
|
||
185860-10-3
|
||
(CUSIP
Number)
|
||
December
31, 2010
|
||
(Date
of Event Which Requires Filing of this Statement)
|
¨
|
Rule
13d-1(b)
|
|
¨
|
Rule
13d-1(c)
|
|
x
|
Rule
13d-1(d)
|
CUSIP
NO.
185860-10-3
|
1 |
NAMES OF REPORTING PERSONS:
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES
ONLY):
|
||||
|
|||||
Andrei
Gudkov
|
|||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP (SEE INSTRUCTIONS): |
||||
(a) o
|
|||||
(b) o
|
|||||
3 | SEC USE ONLY: | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION: | ||||
United
States of America
|
|||||
5 | SOLE VOTING POWER: | ||||
NUMBER
OF
|
1,784,350
|
||||
|
|||||
SHARES
|
6 | SHARED VOTING POWER: | |||
BENEFICIALLY
|
|||||
OWNED
BY
|
|
||||
|
|||||
EACH
|
7 | SOLE DISPOSITIVE POWER: | |||
REPORTING
|
|||||
PERSON
|
1,784,350
|
||||
|
|||||
WITH:
|
8 | SHARED DISPOSITIVE POWER: | |||
|
|||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: | ||||
1,784,350
|
|||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): | ||||
|
|||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): | ||||
6.1%
|
|||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): | ||||
IN
|
Item
5.
|
Ownership of Five
Percent or Less of a Class
|
Item
6.
|
Ownership of More than
Five Percent on Behalf of Another
Person
|
Item
7.
|
Identification and
Classification of the Subsidiary Which Acquired the Security Being
Reported
on by the Parent Holding Company or Control
Person
|
Item
8.
|
Identification and
Classification of Members of the
Group
|
Item
9.
|
Notice of Dissolution
of Group
|
Certification
|
Date:
February 4, 2011
|
ANDREI
GUDKOV
|
|
/s/ Andrei Gudkov
|
||
Name:
Andrei Gudkov
Title:
Chief Scientific Officer
|